Editorial: Advances in Evaluation and Management of Hair Loss Disorders

January 2023 in “ Frontiers in medicine ”

Manuel Valdebran

hair loss genetic factors environmental factors novel medications platelet-rich plasma low-level laser therapy alopecia PRP LLLT

TLDR Early diagnosis and personalized treatments are crucial for better hair loss management.

The editorial "Advances in evaluation and management of hair loss disorders" discusses recent progress in understanding and treating various hair loss conditions. It highlights the importance of early diagnosis and personalized treatment plans, emphasizing the role of genetic and environmental factors in hair loss. The article also reviews new therapeutic approaches, including novel medications and advanced technologies like platelet-rich plasma (PRP) and low-level laser therapy (LLLT). The editorial underscores the need for continued research to improve patient outcomes and develop more effective treatments for alopecia and other hair loss disorders.

View this study on frontiersin.org →

Discuss this study in the Community →

Research cited in this study

11 / 11 results

research Healthcare Utilization And Costs Among US Adolescents With Alopecia Areata

4 citations, July 2022 in “Journal of health economics and outcomes research”

Alopecia areata in US adolescents leads to significant healthcare costs and usage.

research Epidemiological Trends in Alopecia Areata at the Global, Regional, and National Levels

11 citations, July 2022 in “Frontiers in immunology”

Cases of alopecia areata and its impact on life quality rose globally, but when adjusted for age, the rates decreased, especially in poorer regions.

Oral Tofacitinib and Systemic Corticosteroids, Alone or in Combination, in Patients With Moderate-to-Severe Alopecia Areata: A Retrospective Study

research Oral Tofacitinib and Systemic Corticosteroids, Alone or in Combination, in Patients With Moderate-to-Severe Alopecia Areata: A Retrospective Study

8 citations, June 2022 in “Frontiers in Medicine”

Both individual and combined treatments of tofacitinib and corticosteroids can help regrow hair in moderate-to-severe alopecia areata, but ongoing treatment may be necessary.

research Alopecia Areata: Overview and Insights from January 2018

290 citations, December 2017 in “Journal of The American Academy of Dermatology”

Alopecia areata is an autoimmune condition causing hair loss, influenced by genetics, stress, and diet, and may be prevented by a high soy oil diet.

research Objective Outcome Measures: Collecting Meaningful Data on Alopecia Areata

39 citations, November 2017 in “Journal of The American Academy of Dermatology”

The document suggests using standardized methods to track and measure hair loss in alopecia areata, including patient self-assessment and a 50% improvement in specific scores as a treatment goal.

research Alopecia Areata: An Update on Treatment Options for Children

21 citations, May 2017 in “Paediatric drugs”

Individualized treatment plans are crucial for children with alopecia areata, with promising options like JAK inhibitors showing significant hair regrowth.

research Epidemiology and Burden of Alopecia Areata: A Systematic Review

144 citations, July 2015 in “Clinical, Cosmetic and Investigational Dermatology”

Alopecia areata is a common autoimmune disease affecting about 2% of people, causing significant disability and often associated with mental health issues and other autoimmune conditions.

research The Autoimmune Basis of Alopecia Areata: A Comprehensive Review

162 citations, October 2014 in “Autoimmunity reviews”

Alopecia areata is caused by the immune system attacking hair follicles.

research Killing Two Birds with One Stone: Oral Tofacitinib Reverses Alopecia Universalis in a Patient with Plaque Psoriasis

185 citations, June 2014 in “Journal of Investigative Dermatology”

A man with severe hair loss and skin disease regrew his hair with no side effects after taking tofacitinib.

research Genome-Wide Association Study in Alopecia Areata Implicates Both Innate and Adaptive Immunity

717 citations, June 2010 in “Nature”

Alopecia areata involves both innate and adaptive immunity, with specific genes linked to the disease.

research Familial Aggregation of Alopecia Areata

295 citations, January 2006 in “Journal of the American Academy of Dermatology”

Alopecia areata, a common autoimmune hair loss condition, often runs in families.

Similar Research

5 / 1000+ results

research Folliculitis Decalvans: A Review of Current Treatment Modalities

May 2024 in “Journal of Education, Health and Sport”

Current treatments for folliculitis decalvans include antibiotics, isotretinoin, and potential new therapies like botulinum toxin A and PRP.

research Female Pattern Hair Loss: An Update

12 citations, January 2020 in “Indian Dermatology Online Journal”

Female pattern hair loss has multiple causes and treatments, with new therapies showing promise.

research Comparing Current Therapeutic Modalities of Androgenic Alopecia: A Literature Review of Clinical Trials

1 citations, July 2023 in “Cureus”

Some treatments for hereditary hair loss are effective but vary in results and side effects; new therapies show promise but need more research.

research Frontal Fibrosing Alopecia: A Review

23 citations, April 2021 in “Journal of Clinical Medicine”

Frontal Fibrosing Alopecia's cause is unclear, affects mainly postmenopausal women, and current treatments focus on stopping hair loss rather than regrowth.

research Optimal Management of Frontal Fibrosing Alopecia: A Practical Guide

3 citations, November 2020 in “Clinical, Cosmetic and Investigational Dermatology”

Early diagnosis and combination therapy, especially with finasteride and dutasteride, are key to managing Frontal Fibrosing Alopecia effectively.